Senior Business Analyst
VerisartFull Time
Mid-level (3 to 4 years)
Key technologies and capabilities for this role
Common questions about this position
A Bachelor's Degree in Computer Science or Life Sciences (or equivalent) is required, along with six years of IT experience in a Lab setting, preferably including three years as a Business Analyst in Lab/Clinical Trials. Key skills include SQL for querying data, PowerBI for creating prototypes and presenting data, and knowledge of IQVIA data and systems.
Responsibilities include formulating systems scope through research, developing or modifying information systems, analyzing business needs, documenting requirements, using PowerBI for prototypes, querying data with SQL, analyzing Lab Data for stakeholders, and coordinating projects from concept to finalization under general supervision.
This information is not specified in the job description.
This information is not specified in the job description.
Strong candidates will have a degree in Computer Science or Life Sciences, 6+ years IT experience in labs (especially 3+ as a BA in clinical trials), proven SQL and PowerBI skills, and familiarity with IQVIA systems to guide junior analysts and drive projects.
Advanced analytics and clinical research services
IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.